The efficacy of topical bupivacaine and triamcinolone acetonide submucosal injection for pain relief after endoscopic submucosal dissection: a randomized double-blind, placebo-controlled multi-center trial

Hallym University Medical Center-Dongtan0 个研究点目标入组 86 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•We prospectively evaluated consecutive patients with ages of 20 or older who were scheduled to undergo ESD for pathologically diagnosed or clinically suspected gastric adenoma or cancer at Hallym medical center.

•(1) declining to provide informed consent; (2) American Society of Anesthesiology risk Class 3 or higher; (3) severe hepatic disease or cardiopulmonary or renal dysfunction; (4) current analgesics including non-steroidal anti-inflammatory drug use during the preceding week; (5) allergy to bupivacaine or other amide-type local anesthesia; (6) confirmation of any other disease that could induce abdominal pain similar with post-ESD pain; (7) presence of multiple lesions requiring endoscopic resection in one patient; (8) current pregnancy or breast feeding; (9) impossible to assess pain such as severe psychiatric or neurologic disease.

发起方

Hallym University Medical Center-Dongtan